GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getinge AB (OSTO:GETI B) » Definitions » EPS (Diluted)

Getinge AB (OSTO:GETI B) EPS (Diluted) : kr6.22 (TTM As of Sep. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Getinge AB EPS (Diluted)?

Getinge AB's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was kr0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was kr6.22.

Getinge AB's EPS (Basic) for the three months ended in Sep. 2024 was kr0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was kr6.22.

Getinge AB's EPS without NRI for the three months ended in Sep. 2024 was kr0.46. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was kr7.14.

During the past 12 months, Getinge AB's average EPS without NRIGrowth Rate was -23.10% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -8.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Getinge AB's highest 3-Year average EPS without NRI Growth Rate was 22.90% per year. The lowest was -14.20% per year. And the median was 7.70% per year.


Getinge AB EPS (Diluted) Historical Data

The historical data trend for Getinge AB's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getinge AB EPS (Diluted) Chart

Getinge AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.48 11.89 10.90 9.15 8.86

Getinge AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.28 2.64 1.69 1.88 0.01

Competitive Comparison of Getinge AB's EPS (Diluted)

For the Medical Devices subindustry, Getinge AB's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Getinge AB's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's PE Ratio distribution charts can be found below:

* The bar in red indicates where Getinge AB's PE Ratio falls into.



Getinge AB EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Getinge AB's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(2412-0)/272.370
=8.86

Getinge AB's Diluted EPS for the quarter that ended in Sep. 2024 is calculated as

Diluted EPS (Q: Sep. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(2-0)/272.370
=0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr6.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Getinge AB  (OSTO:GETI B) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Getinge AB EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Getinge AB's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Getinge AB Business Description

Traded in Other Exchanges
Address
Lindholmspiren 7A, P.O. Box 8861, Gothenburg, SWE, SE-417 56
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB Headlines

No Headlines